Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Levy Adam D. received 46,167 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Levy Adam D. (Chief Financial Officer) received 46,167 Acrivon Therapeutics, Inc. shares as an award, leaving 67,150 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 46,167 shares
- Holding after
- 67,150 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 46,167 | 67,150 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Levy Adam D.
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Levy Adam D. · Aug 6, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026